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Abstract
A type VI secretion system (T6SS) was recently shown to be required for full virulence of Vibrio cholerae O37 serogroup
strain V52. In this study, we systematically mutagenized each individual gene in T6SS locus and characterized their functions
based on expression and secretion of the hemolysin co-regulated protein (Hcp), virulence towards amoebae of
Dictyostelium discoideum and killing of Escherichia coli bacterial cells. We group the 17 proteins characterized in the T6SS
locus into four categories: twelve (VipA, VipB, VCA0109–VCA0115, ClpV, VCA0119, and VasK) are essential for Hcp secretion
and bacterial virulence, and thus likely function as structural components of the apparatus; two (VasH and VCA0122) are
regulators that are required for T6SS gene expression and virulence; another two, VCA0121 and valine-glycine repeat
protein G 3 (VgrG-3), are not essential for Hcp expression, secretion or bacterial virulence, and their functions are unknown;
the last group is represented by VCA0118, which is not required for Hcp expression or secretion but still plays a role in both
amoebae and bacterial killing and may therefore be an effector protein. We also showed that the clpV gene product is
required for Dictyostelium virulence but is less important for killing E. coli. In addition, one vgrG gene (vgrG-2) outside of the
T6SS gene cluster was required for bacterial killing but another (vgrG-1) was not. However, a bacterial killing defect was
observed when vgrG-1 and vgrG-3 were both deleted. Several genes encoded in the same putative operon as vgrG-1 and
vgrG-2 also contribute to virulence toward Dictyostelium but have a smaller effect on bacterial killing. Our results provide
new insights into the functional requirements of V. cholerae’s T6SS in the context of secretion as well as killing of bacterial
and eukaryotic phagocytic cells.
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Introduction
Pathogenicity of bacteria is often critically dependent on
secretion systems to export toxic molecules into the environment
or translocate effectors into the host cells. These secreted or
injected molecules result in interference with or stimulation of host
cellular processes. At least six different secretion systems (type I
through type VI) have been found in Gram-negative bacterial
pathogens of animals and plants [1,2,3]. These secretion systems
are distinguished in part by the conserved structural components
that define them but also by the characteristics of their substrates
and the subcellular paths that their substrates take during the
export process. Among these secretion systems, type VI secretion
system (T6SS) has recently emerged as an exciting new topic for
experimental exploration [4,5].
T6SSs have been described in many bacterial pathogens and
have been implicated in a variety of functions ranging from inter-
bacterial relationships and biofilm formation, to cytotoxicity and
survival in phagocytic cells [2,6,7,8,9]. T6SS gene cluster can be
found in approximately 25% of all sequenced Proteobacteria and
is a virulence factor in many bacteria including Vibrio cholerae [5],
Edwardsiella tarda [10], Pseudomonas aeruginosa [4], and Burkholderia
species [11,12]. T6SS gene clusters contain from 15 to more than
20 genes and secrete substrates lacking N-terminal hydrophobic
signal sequences [13]. Functional assays and protein localization
studies suggested that the proteins encoded by T6SS gene clusters
are assembled into a multi-component apparatus [10,14,15,16].
Bioinformatic analysis has identified a core of 13 genes that may
constitute the minimal number needed to produce a functional
apparatus [17]. T6SS core components include DotU and IcmF
orthologs believed to stabilize the multi-protein complex in the
membrane [10,18], and an AAA+ family ATPase called ClpV
[4,19]. ClpV associates with several other conserved T6SS
proteins and its ATPase activity has been reported to be essential
for T6SS function [2]. In most T6SSs, hemolysin co-regulated
protein (Hcp) and valine-glycine repeat protein G (VgrG) are
exported by T6SS. They are proposed to be the extracellular
components of T6SS apparatus, and their secretion is co-
dependent [6,10,20,21,22]. Multiple distinct T6SS gene clusters
have been identified in various bacteria [4,5,10,14]. In E. tarda,a
systematic mutation of one T6SS cluster has been performed and
three categories of proteins have been identified, including 12
genes required for the Hcp secretion [10].
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23876V. cholerae is a Gram-negative bacterium that causes a severe,
life-threatening diarrheal disease, cholera. Disease occurs when
contaminated food or water is ingested, resulting in a voluminous
secretory diarrhea that can lead to dehydration and death if
untreated [23]. Orally ingested bacteria colonize the intestinal
epithelium through expression of toxin co-regulated pili (TCP)
which in turn is coordinately regulated with cholera toxin (CT),
the enterotoxin responsible for the bulk of the secretory diarrhea
observed during disease progression [24]. Besides these classic
virulence factors, T6SS was recently implicated as a virulence
determinant of V. cholerae using Dictyostelium discoideum, mouse and
rabbit as model systems [5,25,26]. In V. cholerae O37 serogroup
strain V52, T6SS is required for full virulence towards Dictyostelium
amoebae and J774 macrophages [5] and for the inflammatory
diarrhea in infant mice [25]. In the seventh pandemic O1 El Tor
strain C6706, T6SS contributes to fecal diarrhea and intestinal
inflammation in infant rabbits [26]. In addition, T6SS in V. cholerae
displays antimicrobial properties and can cause up to a 100,000-
fold reduction in Escherichia coli K12 survival when they co-
cultivated with V. cholerae strain V52 on solid agar media [9].
T6SS in V. cholerae is responsible for the secretion of Hcp as well
as three VgrG proteins (VgrG-1 to -3) [5]. VgrG-1, which
functions as both a T6SS structural element and an effector
protein [20], contains a C-terminal domain with strong homology
to the actin cross-linking domain (ACD) of V. cholerae RtxA or
MARTX toxin [27]. VgrG-1 causes actin cross-linking in host cells
following its T6SS-dependent translocation during infection
[20,25,28]. However, the ACD domain of VgrG-1 is not required
for killing E. coli [9]. VgrG-1 is the only effector protein
demonstrated to be translocated into eukaryotic host cells by a
functional T6SS. However, recently several proteins have been
identified as being likely translocated into bacterial target cells by
the T6SS of P. aeruginosa [6].
Structural biology has revealed interesting evolutionary rela-
tionships between components of the T6SS apparatus and other
dynamic structures that penetrate cell membranes [20,21]. For
example, the X-ray crystal structure of an E. coli VgrG-related
protein predicts that VgrG proteins likely trimerize to form a
complex that strongly resembles the bacteriophage T4 tail spike
complex [20,21]. The atomic structure of Hcp-related protein
from Pseudomonas aeruginosa [4] revealed its ability to form tube-like
structures in crystals that are similar to tubes formed by the N-
terminal domain of trimeric VgrG proteins [21,22]. These data
suggest that in the context of a T6SS appratus, Hcp may form a
tube-like structure that interacts with VgrG trimers in a complex
analogous to phage tail tubes and spikes [21,22]. Other T6SS
proteins also have domains that are similar to phage tail base plate
proteins [21].
In the V. cholerae V52 T6SS locus, VipA, VipB, VasH, VasF,
ClpV, VasK, and VgrG-3 have been characterized by genetic
knockout [5,19] and bioinformatic analysis [29]. VasH is a
regulator and VipA, VipB, VasF, ClpV and VasK are T6SS
structural components essential for Hcp secretion [5,19,20]. VipA
binds to VipB and they together form tubules in E. coli [19] that
Leiman et al. [21] first noted have a striking resemblance to
structures corresponding to the contracted tail sheath of
bacteriophage T4. Thus, a phage sheath-like contraction mech-
anism might power the membrane penetration/secretion process
of the VgrG-Hcp portion of the T6SS phage tail-like apparatus
[3,21]. ClpV ATPase activity can remodel VipA/VipB tubules in
vitro and the ATPase activity of this protein has been reported to be
a critical for substrate secretion in P. aeruginosa and V. cholerae
[4,19].
Here we report the genetic analysis of the T6SS locus of V.
cholerae V52 in the context of its role in virulence against both E.
coli and Dictyostelium amoebae. Our results show that deletion of 15
individual genes in the T6SS locus result in loss of virulence
toward amoebae. Twelve of these 15 individual genes are required
for secretion of Hcp but not its expression. Another two VCA0118
and VCA0122 encode a potential effector protein and a regulator,
respectively. In addition, we show that several genes in the
putative operons that encode vgrG-1 and vgrG-2 are likely involved
in type VI secretion and affect T6SS-dependent virulence toward
amoebae. Deletion of any of the genes predicted to encode T6SS
structural elements caused significant decreases in the ability of V.
cholerae to kill E. coli. Additionally, the regulatory gene vasH,
VCA0118 and VCA0020 also contribute to T6SS-dependent
killing of bacterial cells.
Results
Systematic mutagenesis of genes in the T6SS locus
The T6SS locus in V. cholerae contains 18 open reading frames
[5]. Additionally, VCA0118, VCA0121 and VCA0122 have been
found to be restricted to a smaller group of T6SS
+ organisms and
could have species-specific roles [29]. While some genetic analysis
of VipA, VipB, VasF, VasH, ClpV, VasK and VgrG-3 has been
performed previously [5,19,20], the function of other proteins
encoded in this locus have not been explored in terms of their
participation in both bacterial and eukaryotic T6SS-dependent
killing. Thus, we began by systematically mutating all genes
predicted to be in the T6SS locus of V. cholerae strain V52 (Fig. 1A).
We generated non-polar mutations by making in-frame deletions
within each gene. Thirteen mutants were successfully constructed
but we were unable to delete any portion of VCA0124 for
unknown reasons. VCA0124 may be essential and could encode
an immunity protein for a toxic effector as has been reported for
the P. aeruginosa T6SS [6].
In order to determine the effects of these mutations on T6SS
activity, standard Hcp expression and secretion assays were
performed utilizing western blot analysis and anti-Hcp antibody.
Protein fractions were prepared from bacterial cell pellets and cell-
free supernatant fluids from 16 T6SS mutants (Dvca0107 to
Dvca0122). As shown in Fig. 1B, Hcp was detected in the bacterial
cell pellet of all the mutants except DvasH. In addition, Hcp
expression was significantly decreased in Dvca0122 compared to
wild type and other T6SS mutants (excluding DvasH), suggesting
that VCA0122 may either promote the expression of T6SS
substrates as a regulator or their stabilization as a chaperone.
Because Ponceau S staining of the western blot membranes
showed a similar total protein level among the different mutants
analyzed (data not shown), we conclude that the different levels of
Hcp observed in the bacterial pellets was not due to sample
loading variation during the analysis. Expression of Hcp in the cell
pellet did not predict whether Hcp would be secreted by a given
mutant. Thus, we examined the presence of Hcp in the
supernatant fluids of mutants. As shown in Fig. 1B, Hcp could
not be detected in the supernatant fluids of mutants in twelve
genes (VCA0107 through VCA0116, VCA0119, and VCA0120)
even though deletion of these genes did not affect Hcp expression
in the cell pellet. In addition, the level of Hcp in the Dvca0122
mutant supernatant was significantly reduced when compared to
wild type (Fig. 1B). VCA0118 and VCA0121 were not required for
wild-type levels of Hcp secretion (Fig. 1B).
To further characterize the effects of these non-polar single gene
mutations on V. cholerae virulence, we examined plaque formation
by Dictyostelium amoebae on bacterial lawns produced with
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individual mutants on SM/5 agar plates and then 5 ml of SorC
buffer containing different numbers of amoebae was deposited on
each of these bacterial lawns. Plaque formation was examined
after 3–5 days of incubation at 22uC, and the minimum number of
Dictyostelium cells required for plaque formation was recorded. As
shown in Fig. 1C, 10,000 Dictyostelium amoebae were required to
form plaque on V52 wild type lawns. However, 5–10 amoebae
cells were sufficient to do so on the lawns of 14 mutants carrying
deletions in Dvca0107 through Dvca0120. The minimum number
of Dictyostelium cells required to form plaques on a Dvca0122 lawn
was 10–50 amoebae cells, slightly higher than other mutants. In
contrast, VCA0121 was not required for virulence in that it
behaved identically to wild type in these amoebae plaque
formation assays. The virulence of the Dvca0121 mutant towards
Dictyostelium is consistent with the observation that this mutant still
secretes normal levels of Hcp (Fig. 1B). Similarly, deletions of two
genes (VCA0105 and VCA0106) encoded upstream of VCA0107
did not shown any significant Dictyostelium killing defect (Fig. 1A &
C), suggesting that these genes are outside the boundary of the
functional T6SS locus.
VCA0122 controls Hcp expression at the transcriptional
level
VCA0122 is a gene found only in Vibrio species and encodes a
protein of 80 amino acids with no recognizable conserved
domains. The Dvca0122 mutant expressed decreased levels of
Hcp in the bacterial pellet as well as in its culture supernatant
(Fig. 1B). To determine whether VCA0122 is required for
transcription of T6SS genes, we examined the expression of hcp-
2 in the Dvca0122 mutant. We constructed on low copy-number
plasmid pTL61T a transcriptional fusion between the promoter
region of hcp-2 gene and a lacZ reporter gene. The resulting
plasmid (pTL-hcp) was then transformed into wild type V52 and
Dvca0122 respectively and the b-galactosidase activities of these
two strains were examined. As shown in Fig. 2, strong b-
galactosidase activity was detected in the bacterial lysate of V52
with pTL-hcp. In contrast, this activity was decreased by about 4-
fold in the Dvca0122 mutant. The decrease in b-galactosidase
activity was partially complemented by a copy of VCA0122
provided in trans (Fig. 2). Taken together, these results suggest that
VCA0122 is a regulator controlling the expression of the hcp-2
locus.
VCA0118 is not required for VgrG-1 secretion but
enhances actin cross-linking activity in a macrophage cell
line
VCA0118 encodes a protein that is 227 amino acids in length
and contains a conserved uncharacterized domain, DUF3121.
VCA0118 homologs can be found in various strains of Vibrio as
well as many other bacterial species, including E. coli, Aeromonas
hydrophila, and Pseudomonas putida. However, VCA0118 is absent
from many other T6SS
+ organisms [29], suggesting that it does
not encode an essential structural component of the T6SS
Figure 1. Characterization of deletion mutants in V. cholerae T6SS locus. (A) Schematic representation of genes organisation in V. cholerae
T6SS locus. Genes that have been characterized were represented by arrows filled with different patterns and genes that have not been characterized
were shown with empty arrows. (B) Hcp expression in bacterial pellet (P) and secretion in culture supernatant (S) in different T6SS deletion mutants
were examined by western blot with anti-Hcp serum. (C) D. discoideum plaque formation assay for individual T6SS deletion mutant. The minimum
number of Dictyostelium amoebae cells required for plaque formation on the lawns of V. cholerae wild type or mutants was shown.
doi:10.1371/journal.pone.0023876.g001
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phenotype than the other 15 deletion mutants in terms of its Hcp
secretion profile and virulence towards Dictyostelium amoebae
(Fig. 1B & C). Deletion of VCA0118 has no significant effect on
Hcp expression or its secretion into the supernatant in vitro
(Fig. 1B). However, Dvca0118 is avirulent to Dictyostelium amoebae.
As shown in Fig. 3A, 10,000 amoebae cells are required to form
plaques on wild type V52 lawns, while only 5 amoebae are needed
to form a plaque on Dvca0118 mutant lawns. This defect was
partially recovered when VCA0118 was expressed in trans (data not
shown).
We also examined whether VCA0118 was required for the
secretion of VgrG-1, the only T6SS effector required for
Dictyostelium and macrophage virulence so far reported for V.
cholerae [20]. As shown in Fig. 3B, Hcp and an epitope-tagged
version of VgrG-1 (HA-VgrG-1) were expressed at a similar level
in wild type V52, Dvca0118 and DvasK. Deletion of vasK totally
abolished Hcp and VgrG-1 secretion into culture supernatant. In
contrast, deletion of vca0118 did not affect secretion of VgrG-1 and
Hcp, both of which were detected in the culture supernatant at a
similar level as was seen in wild type V52. Previous reports showed
that V52 uses T6SS to translocate VgrG-1 into macrophage J774
cells, where the ACD domain of VgrG-1 causes actin cross-linking
[20,28]. In these studies, the addition of bafilomycin A, a specific
inhibitor of vacuolar acidification, enhanced the VgrG-1-depen-
dent, actin cross-linking activity seen in target cells [28]. Because
VCA0118 is required for virulence of V. cholerae towards
Dictyostelium amoebae but is not essential for the secretion of Hcp
or VgrG-1, we tested if the deletion of VCA0118 affected VgrG-1-
dependent actin cross-linking activity in infected J774 macro-
phages. For these experiments, background actin cross-linking
activity was eliminated by disrupting rtxA in all the V. cholerae
strains tested [20,28]. Consistent with previous reports [20,28],
V52 DrtxA induced cross-linking of cytosolic actin in J774 cells
after a 3-hour infection (Fig. 3C). Interestingly, while double DrtxA
vca0118 mutant still induced actin cross-linking in the presence or
absence of bafilomycin A, the actin cross-linking activity we
observed was less pronounced than its V52 DrtxA parental strain
(Fig. 3C). As expected, no actin cross-linking was detected in
macrophages infected with DrtxA vasK or DrtxA vgrG-1 double
mutants (Fig. 3C). These results suggest that VCA0118 contributes
in some way to the delivery or activity of the actin cross-linking
domain of VgrG-1 within J774 mammalian macrophages and
likely within D. discoideum amoebae as well.
Other genes in vgrG-1 and vgrG-2 operons contribute to
virulence
The V. cholerae T6SS substrates Hcp-1, VgrG-1, Hcp-2, and
VgrG-2 are encoded outside of T6SS locus. Bioinformatic analysis
using Promscan [30] and Transterm [31] suggest that hcp-1, vgrG-1
and the five downstream open reading frames (VC1417 to
VC1421) use the same promoter upstream of hcp-1 and the same
terminator downstream of VC1421 (Fig. 4A). Similarly, vgrG-2 and
the three downstream open reading frames (VCA0019 to
Figure 2. VCA0122 is a positive regulator of T6SS. The regulation
of VCA0122 on T6SS substrate gene hcp-2 was examined using lacZ
reporter plasmid. Bacteria were cultured in LB broth. The values
represent the mean 6 SD. Data were analyzed with student’s t test.
** indicates p,0.001 and * indicates p,0.05.
doi:10.1371/journal.pone.0023876.g002
Figure 3. VCA0118 is a virulence factor. (A) D. discoideum plaque
formation assay for Dvca0118 (plate b) and its complementation strain
(plate c). The plaques formed by amoebae on the lawns of V. cholerae
wild type (plate a) or wild type with empty plasmid (plate d) were also
shown as controls. The number of Dictyostelium amoebae cells
deposited on the plate was 1) 5610
4;2 )1 610
4;3 )5 610
3;4 )1 610
3;
5) 5610
2;6 )1 610
2;7 )5 610
1;8 )1 610
1;9 )5 610
0, respectively. (B)
Western blot showed that VCA0118 is not required for Hcp and VgrG-1
secretion. (C) Mutation of VCA0118 reduced but does not abolish actin
cross-linking by VgrG-1 with or without bafilomycin A.
doi:10.1371/journal.pone.0023876.g003
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(Fig. 4A). All proteins encoded in these putative vgrG-1 and vgrG-2
operons are uncharacterized proteins and most of them do not
contain conserved domains (Table S1). Interestingly, bioinformatic
analysis using HHPRED [32] identified very weak structural
homology of VCA0020 and VCA0021 to colicins and type III
secretion system components, respectively (Table S2 and S3).
We deleted all the five genes following vgrG-1 (VC1417 through
VC1421) to get the mutant Dvc17–21 and deleted the single gene
(VC1418) to get the mutant Dvc1418. Similarly, we deleted all
three genes following vgrG-2 (VCA0019 through VCA0021) to get
the mutant Dvca19–21 and deleted the single gene (VCA0020) to
get the mutant Dvca0020. We then examined the virulence of each
of these mutants towards Dictyostelium amoebae. As shown in
Fig. 4B, on average at least 7,500 amoebae cells were required for
plaque formation on wild type lawns. For each of the mutants, the
minimum number of Dictyostelium cells required to form plaques
decreased significantly. The most notable of these was the Dvca19–
21 mutant which supported plaque formation with an average of
only 300 amoebae cells (Fig. 4B). These results suggest that other
genes in the vgrG-1 and vgrG-2 putative operons might contribute
to V52 virulence toward Dictyostelium amoebae. Since T6SS is the
major V. cholerae virulence factor towards Dictyostelium and loss of
T6SS activity abolished the virulence to amoebae cells [5], we
tested whether the Dvca19–21 mutation affected T6SS function.
Culture supernatant fluids from wild type V52 and the Dvca19–21
and Dvc17–21 mutants were examined for Hcp secretion by
western blot. As shown in Fig. 4C, the deletion of VCA0019
through VCA0021 or VC1417 through VC1421 decreased Hcp
secretion. Ponceau S staining of the western blot membrane
showed a similar amount of other unknown secreted proteins had
been loaded in each lane, suggesting the differences in Hcp
secretion were not due to sample loading variation. A similar
reduction in Hcp secretion was also observed in the single deletion
Figure 4. Genes encoded in the vgrG-1 and vgrG-2 operons contribute to V. cholerae virulence and Hcp secretion. (A) Schematic
representation of genes organization in the putative vgrG-1 and vgrG-2 operons. The prompters predicted by PromScan and the terminitors predicted
by TransTerm were indicated by arrows and stars respectively. (B) The minimum number of Dictyostelieum amoebae cells required to form plaque on
the lawns of different mutants in vgrG-1 and vgrG-2 operons. (C) Deletion of genes in vgrG-1 and vgrG-2 operons affected Hcp secretion examined by
western blot. A 37 kD unknown protein demonstrated by Ponceau S staining was used as a control to show the equal protein loading.
doi:10.1371/journal.pone.0023876.g004
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suggest that genes encoded in vgrG-1 and vgrG-2 putative operons
also contribute to secretion by the T6SS and its function in
virulence towards Dictyostelium amoebae.
The antibacterial properties of different T6SS-related
mutants
Recently, T6SS has been implicated in the killing of other
bacterial species by P. aeruginosa, Burkholderia thailandensis and V.
cholerae [6,8,9]. To test the contribution of each T6SS gene to the
antibacterial properties of V. cholerae, we examined whether each
of these mutants could kill E. coli when grown in competition on
agar plates. V. cholerae and E. coli K12 were mixed, spotted onto
Luria-Bertani (LB) agar plates and incubated at 37uCf o r
3.5 hours. Surviving E. coli K12 cells were then recovered from
the plate and enumerated by quantitative plate counts. As
previously reported [9], V. cholerae V52 is highly virulent toward
E. coli K12 and literally no viable E. coli cells were recovered from
these plates (Fig. 5A). In contrast, deletion of VCA0107 (vipA)
through VCA0115 (vasF), or deletion of VCA0117 (vasH),
VCA0119 and VCA0120 (vasK) resulted in complete loss of E.
coli killing. Under the assay conditions used, T6SS-dependent
killing was responsible for a 1,000 to 10,000-fold drop in the
recovery of viable E. coli cells. Furthermore, these results were
remarkably consistent with the requirement of these same genes
for Dictyostelium amoeba killing (Fig. 1C). Thus this group of genes
likely represents the set of genes required for producing a
functional T6SS apparatus. Remarkably, deletion of clpV
(VCA0116) also resulted in a clear attenuation in the bacterial
killing, but not to the same degree as seen in mutants in the genes
VCA0107–VCA0115, VCA0117, VCA0119 and VCA0120.
Compared to these T6SS apparatus knockout mutants, approx-
imately 30-fold fewer viable E. coli cells were recovered from the
competitions with the DclpV mutant, indicating that significant
killing activity could still be detected in the DclpV mutant.
Similarly, deletion of VCA0118 caused an attenuation of E. coli
killing activity in that about 2-fold fewer E.coli were recovered
compared to DclpV. In contrast, loss of VCA0105, VCA0106,
VCA0121 and VCA0122 had no significant effect on bacterial
killing (Fig. 5A).
We then examined the antibacterial properties of the three
VgrG proteins (VgrG-1 to -3). As shown in Fig. 5B, deletion of
vgrG-2 resulted in complete loss of killing. Surprisingly, we did not
observed a significant bacterial killing defect in the DvgrG-1 and
DvgrG-3 mutants. However, simultaneous deletion of both of these
genes (DvgrG-1/3) produced a similar phenotype as DvgrG-2 and
other T6SS apparatus knockout mutants. In addition, deletion of
hcp-1 and hcp-2 together (Dhcp-1/2) also led to loss of bacterial
killing. The genes in the vgrG-1 and vgrG-2 putative operon were
also evaluated. There is no noticeable bacterial killing defect in
Dvc1418 or Dvc17–21. However, deletion of VCA0020 caused a
slight attenuation in E. coli killing. Interestingly, this defect was not
observed in Dvca19–21, in which all three genes following vgrG-2
(VCA0019 through VCA0021) were deleted (Fig. 5B).
Figure 5. The contributions of different T6SS-related mutants on V. cholerae antibacterial properties. Survival of tetracycline-resistant E.
coli CC114 was determined by measuring cfu following exposure to the streptomycin-resistant V. cholerae predator listed on the x-axis. The data
represent three independent experiments and values given are means 6 SD.
doi:10.1371/journal.pone.0023876.g005
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not required for Hcp secretion
A bioinformatic analysis of proteins in V. cholerae T6SS locus did
not predict any proteins with a trans-membrane domain that
might provide an outer membrane channel for secretion of T6SS
effectors [29]. We thus asked whether outer membrane proteins
from other secretion systems might be involved in type VI protein
secretion. V. cholerae contains a type II secretion system in addition
to its T6SS [33]. We deleted EpsD (VC2733), the outer membrane
channel of type II secretion system. The secreted proteins from
bacterial culture supernatant were collected and Hcp was
examined by western blot. Although EpsD deficiency greatly
impaired growth of V. cholerae (data not shown), Hcp was readily
detected in the bacterial supernatant (Fig. 6), suggesting that T6SS
in V. cholerae does not make use of type II secretion system channel
for secretion of its substrates.
Discussion
Using a D. disoideum model, the T6SS of V. cholerae was identified
and designated a virulent determinant of V. cholerae O37 strain V52
toward amoebae [5] and toward mice [9]. More recently the T6SS
of V52 was also shown to have antibacterial activity [9]. In this
study, to further understand T6SS in V52, we undertook a
systematic mutagenesis approach. We characterized each mutant
for Hcp expression and secretion, and examined their contribu-
tions to virulence with Dictyostelium amoebae and E. coli.W e
identified four groups of proteins encoded in the T6SS locus:
structural apparatus components, regulators, proteins of unknown
function and a potential effector.
VipA, VipB, VasF, ClpV and VasK have been shown to be
essential for Hcp secretion in O37 serogroup strain V52 in
previous reports [5,19]. Here we identified another 7 genes
(VCA0109 through VCA0114, and VCA0119) required for Hcp
secretion in V52. Deletion of these genes totally abolished Hcp
secretion even though their expression levels remained similar to
wild type. These mutants were also avirulent towards Dictyostelium
amoebae and E. coli bacteria. Thus we speculate that collectively
these genes constitute important components of the T6SS
apparatus (Table 1). Deletion of T6SS structural components of
the T6SS apparatus might cause defects in either secretion or
translocation of T6SS effectors, either of which would likely
compromise virulence.
Interestingly, deletion of clpV (VCA116) has a similar effect on
Hcp secretion and attenuation in Dictyostelium virulence as deletion
of other T6SS apparatus genes but a relatively smaller effect on
killing activity towards E. coli. These data suggest that ClpV is not
essential for the process that ultimately allows V. cholerae to kill E.
coli by a T6SS-dependent mechanism but rather simply increases
its efficiency. Given the pore-like structure and protein transloca-
tion capability of Clp family proteins, there has been speculation
that ClpV may provide the energy to translocate T6SS substrates
out of bacterial cells and into target cells [4,19]. Indeed, a ClpV
ortholog has also been shown to be essential for secretion of Hcp in
P. aeruginosa [4] and for bacterial killing [6]. ClpV of V. cholerae has
previously been shown to be required for remodeling of the
tubular complex formed by the products of VCA107 (VipA) and
VCA108 (VipB) as well as efficient secretion of Hcp and VgrG-2
proteins [19]. Our results suggest that ClpV may not be required
for assembly of a functional T6SS apparatus but rather simply
improves the efficiency of its function. Because the tubular
structure formed by VipA and VipB resembles contracted tail
sheath of bacteriophage T4, Leiman et al. [21] first suggested that
the T6SS-mediated secretion and membrane insertion process
might be powered through conformational changes in VipA and
VipB that mimic those occurring in phage tail contraction (rather
than through the energy generated by ClpV ATP hydrolysis). It
follows that, in the absence of ClpV such a phage tail-like
contraction mechanism might also insert the VgrG spike and Hcp
tube structure [20,21] into closely contacted E. coli target cells. The
non-essentiality of ClpV for V52 killing of E. coli is consistent with
the hypothesis that ClpV is not essential for formation and
function of the T6SS apparatus per se. Rather ClpV might play its
role in the disassembly of the contracted VipA/B sheath-like
structure [3,21] (after a bacterial killing event) and thus likely
improve the efficiency of killing by recycling VipA/B out of
contracted sheath-like structures and back into functional non-
contracted T6SS phage tail-like assemblies. A few functional T6SS
assemblies might be sufficient to kill detectable numbers of E. coli
cells in our sensitive bioassay, whereas a larger number of T6SS
assemblies (or the rapid recycling of contracted sheath-like
assemblies) may be needed to translocate detectable amounts of
effector proteins into supernatant fluids and into amoebae or other
types of target cells.
Although V. cholerae encodes three VgrG proteins, we found that
VgrG-2 is the only VgrG protein individually essential for
secretion as well as killing of amoebae and bacteria. VgrG-1 is
essential for Hcp secretion and amoebae killing [5,20,28] but not
for killing of E. coli (Fig. 5B) [9]. This curious fact suggests that
bacterial killing may occur by a process that does not generate a
large amount of extracellular Hcp and that the T6SS apparatus
that mediates this killing can still be assembled in the absence of
VgrG-1. It is possible that like ClpV, some T6SS-related proteins
are not absolutely required for assembly or function of the
apparatus, but rather alter the efficiency of its assembly or
reassembly. For example, despite the fact that inactivation of
VgrG-1 or VgrG-3 alone does not affect bacterial killing,
inactivation of both of these genes does block killing. Because
VgrG-2 interacts with VgrG-1 and VgrG-3 [20], we propose that
VgrG-2 likely needs to interact with one of these other VgrG
proteins to efficiently form a critical component of the T6SS
apparatus such as a homo- or heterotrimer of VgrG-2.
VgrG-2 is the shortest of the three V. cholerae VgrG proteins and
carries virtually no C-terminal extension domain. Leiman et al.
[21] noted that short VgrG proteins are the most common form
found among the hundreds of VgrG proteins encoded by
microbial genomes. Thus, the short form of VgrG proteins may
be the essential form of the protein conferring anti-bacterial
activity through its ability to puncture cells using its needle-like
b-helix C-terminal domain [21]. By analogy to phage tail-like
pyocins [34], the T6SS phage tail-like spike and needle
penetration would be followed quickly by lethal channel formation
via insertion of the phage tube-like Hcp structure through the
envelop of the target cell [21]. Recently, the T6SS of P. aeruginosa
Figure 6. Type II secretion system outer membrane protein
EpsD is not requited for Hcp secretion. Western blot of Hcp from
the cell-free supernatant fluids of V. cholerae wild type and DepsD with
anti-Hcp was shown.
doi:10.1371/journal.pone.0023876.g006
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of soluble toxic effector proteins [6]. Other than the anti-
eukaryotic ACD effector domain of VgrG-1 [5,20,25,28], we
have not uncovered a separate anti-bacterial effector in the present
study and thus conclude that a functional T6SS apparatus may be
sufficient for V. cholerae to kill E. coli. However, it is worth
emphasizing that killing different bacterial or eukaryotic targets
and using different killing mechanisms, such as membrane
breaching versus delivering a separate toxic effector protein,
might all require different threshold levels of T6SS assemblies. For
example, pyocins kill with single hit kinetics (i.e., insertion of one
pyocin can kill one bacterial cell) but soluble protein bacteriocins
likely require more than one molecule to be translocated into a
target cell in order to kill [34].
Four genes in the T6SS cluster of V. cholerae are not absolutely
required for secretion of Hcp including vasH, VCA0118,
VCA0121, and VCA0122 (Table 1). VCA0121 is also not
required for virulence toward amoebae and bacteria. A bioinfor-
matic analysis showed that both VCA0119 and VCA0121 have
ImpA-rel-N superfamily domains, a feature found in inner
membrane proteins participating in intracellular protein transport
[29]. VCA0119 is important for T6SS-dependent secretion
(Fig. 1B &C), suggesting that VCA0121 might simply be a non-
functional derivative of a VCA0119 duplication. However, given
their low sequence similarity (12.7% identity) it is also possible that
VCA0121 was acquired by horizontal gene transfer from a non-
Vibrio species and may have some as of yet undetermined function.
The expression of T6SS gene clusters is typically tightly
regulated [1,2,3]. Before this study, four regulators have been
shown to control T6SS in V. cholerae, namely, VasH, TsrA, HapR
and RopN [5,26,35]. VasH is a sigma-54 dependent regulator
encoded in T6SS locus and is required for Hcp expression [5].
TsrA is a global regulator that represses transcription of genes for
T6SS and virulence factors (CT and TCP) and activates the gene
for the secreted hemagglutinin protease HapA [26]. Both HapR
and RpoN are positive regulators for T6SS transcription, and
RpoN has been shown to directly bind to the hcp-1, hcp-2, and vipA
promoter regions [26,36]. Here, we found that VCA0122 is an
additional regulator for V. cholerae T6SS. VCA0122 is an 80 amino
acid protein and is not homologous to any characterized protein.
Mutation of VCA0122 decreased Hcp expression at the
transcriptional level presumably by affecting hcp-2 promoter
activity. Interestingly, VCA0122 plays important role in the
Dictyostelium killing but seems to have no contribution to T6SS-
dependent bacterial killing. Deletion of VCA0122 decreased but
did not abolish Hcp expression and secretion (Fig. 1B). It is likely
that the number of functional T6SS assemblies in Dvca0122 is
sufficient to kill bacteria but not eukaryotic cells.
VCA0118 is a 227 amino acid-long protein and predicted to be
exported [29]. It contains a DUF3121 superfamily domain,
which has no characterized function. In V. cholerae, VCA0118 is
different from all other proteins encoded in the T6SS locus in
that deletion of VCA0118 did not affect the secretion of Hcp or
VgrG-1, the only known eukaryotic effector protein of T6SS, but
Table 1. Functions of genes encoded in T6SS locus of V. cholerae V52.
Required for
Gene Function Hcp Secretion?
Virulence toward
amoebae Bacteria killing References
VCA0107 (vipA) Structure protein Yes Yes Yes This study and [19]
VCA0108 (vipB) Structure protein Yes Yes Yes This study and [19]
VCA0109 Structure protein Yes Yes Yes This study
VCA0110 (vasA) Structure protein Yes Yes Yes This study
VCA0111 Structure protein Yes Yes Yes This study
VCA0112 Structure protein Yes Yes Yes This study
VCA0113 Structure protein Yes Yes Yes This study
VCA0114 Structure protein Yes Yes Yes This study
VCA0115 (vasF) Structure protein Yes Yes Yes This study and [5]
VCA0116 (clpV) Structure protein Yes Yes Yes/No
a This study and [19]
VCA0117 (vasH) Regulator Yes Yes Yes This study [5]
VCA0118 Putative effector No Yes Yes/No
a This study
VCA0119 Structure protein Yes Yes Yes This study
VCA0120 (vasK) Structure protein Yes Yes Yes This study
VCA0121 Unknown No No No This study
VCA0122 Regulator No
b Yes No This study
VCA0123 (vgrG-3) Unknown/Secreted protein No No Yes/No
d This study and [20]
VC1415 (hcp-1
c),
VCA0017 (hcp-2
c)
Structure/Secreted protein Yes Yes Yes This study and [5]
VC1416 (vgrG-1) Structure protein/Effector Yes Yes Yes/No
d This study and [20]
VCA0018 (vgrG-2) Structure/Secreted protein Yes Yes Yes This study and [20]
aclpV and VCA0118 mutants exhibited bacterial killing activity but at a significantly lower level than wild type.
bVCA0122 enhances Hcp expression and secretion. The VCA0122 mutant exhibited a slightly lower level of Hcp expression than wild type.
chcp-1 and hcp-2 fully complement each other. Their requirement for virulence is only observed in the context of the double knock-out.
dvgrG-1 and vgrG-3 are able to complement each other for E. coli killing activity only. The double mutant is avirulent toward E. coli.
doi:10.1371/journal.pone.0023876.t001
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Further investigation of actin cross-linking showed that the
VCA0118 mutant was still able to cause actin cross-linking but at
a lower efficiency than its V52 DrtxA parental strain (Fig. 3C).
These results suggest that VCA0118 might be required for
efficient translocation of VgrG-1 into host cell. Given that
endocytosis of V. cholerae is required to observe actin cross-linking
[5,25,26], VCA0118 may represent an extracellular adhesin that
promotes binding and phagocytosis of V. cholerae by macrophages.
VCA0118 might also participate in the translocation of T6SS
effectors into target cells after phagocytosis of V. cholerae.I f
VCA0118 protein is also translocated into the host cell, then it is
also possible that it might interact with VgrG-1 to promote
VgrG-1 actin cross-linking activity within the host cell cytoplasm.
However, considering inactivation of VCA0118 causes a total loss
of virulence toward Dictyostelium but only slightly decreases actin
cross-linking, it seems unlikely that VCA0118 functions only
through its interaction with VgrG-1, as deletion of VCA0118 also
decreased virulence toward E. coli, which does not require VgrG-
1 or its ACD domain (Fig. 5B) [9], these data suggest that
VCA0118 likely plays some other role besides being an enhancer
of VgrG-1 toxicity. Further experiments will be needed to define
the exact contribution that VCA0118 makes to the functionality
of the T6SS of V. cholerae.
In addition to the proteins encoded in T6SS locus, we also
defined several additional genes that are possibly involved in T6SS
function. The genes encoded downstream of vgrG-1 and vgrG-2
contribute to the virulence of V52 toward Dictyostelium. Deletion of
a single gene (VCA0020) caused attenuation of V52 virulence
toward amoebae, possibly by causing a small decrease in Hcp
secretion (Fig. 4C). The attenuation level in this mutant as well as a
triple mutant lacking genes VCA0019–VCA0021 was relatively
small compared to the decreases in virulence caused by deletion of
T6SS apparatus genes, suggesting that they do not encode
essential structure components of the apparatus. In the bacterial
killing assay, deletion of VCA0020 showed a decreased virulence
toward E. coli. Interestingly, this attenuation was not seen in
DVCA19–21 in which the genes VCA0019–VCA0021 were
deleted as a block. This result suggests that VCA0020 may
interact with VCA0019 and VCA0021 in a complex way that
affects the functionality of the T6SS apparatus in killing assays.
Consistent with these results, Miyata et al. [37] have recently
reported that mutation in VCA0020 significantly reduced
virulence of V. cholerae toward Dictyostelium without altering
secretion of Hcp or VgrG proteins.
In conclusion, we have shown in this study that proteins
encoded in V. cholerae T6SS locus contribute in different ways to its
functionality in Hcp secretion and the killing of amoebae and
bacteria. Since T6SS is an important virulence factor in many
bacterial pathogens, the characterization of gene products that are
absolutely required for the functionality of the T6SS apparatus
should benefit the understanding of T6SS mechanism in other
bacterial species and may provide new targets for control of
bacterial infectious diseases.
Material and Methods
Strains, plasmids and culture conditions
V. cholerae O37 serogroup strain V52 and its derivatives were
used in this study. E. coli strains DH5alpir, and SM10lpir were
used for cloning and mating, respectively. The bacterial strains
and plasmids used in this study were listed in Table 2. All bacterial
strains were grown in LB broth supplemented with streptomycin
(800 mg/ml), kanamycin (50 mg/ml), and carbenicillin (50 mg/ml)
when necessary. Macrophage J774 cells were obtained from the
American Type Culture Collection (ATCC). D. discoideum strain
AX3 was used for bacterial virulence assay. AX3 was grown in
liquid HL5 cultures or SM/5 agar plate as described by Pey [38].
Non-polar deletion mutants and LacZ reporter plasmid
construction
Overlap extension PCR was used to generate in-frame deletion
of individual genes as described previously [39]. Briefly, for
construction of a gene X deletion mutant, two PCR fragments
were generated from V52 genomic DNA with the primer pair of
X-for plus X-int-rev, and X-rev plus X-int-for. The resulting
products generated about 1 kb fragment containing the upstream
of gene X and a 1 kb fragment containing the downstream of gene
X, respectively. A 20-bp overlap sequences (underlined) in the
primers permitted amplification of an about 2 kb product during a
second PCR with the primers X-for and X-rev. The resulting PCR
product contained a deletion of the internal fragment of gene X.
This PCR product was then sub-cloned into plasmid pDS132 [40]
to result in a suicide plasmid construct. Non-polar deletion
mutants were generated by sacB-based allelic exchange. The
primers are listed in Table S4, and the restriction sites introduced
in the primers were indicated as bold face. Mutants were verified
by PCR. For construction of LacZ reporter plasmid, hcp-2 putative
promoter region was amplified from V. cholerae V52 genomic DNA
and the PCR products were subcloned into XhoI and XbaI digested
pTL61T plasmid [41].
Protein assay
Secreted proteins were isolated from mid-log cultured V. cholerae
(OD600=0.4,0.5) in LB broth. Briefly, various overnight
bacterial cultures were diluted at 1:1,000, and were grown for
about 3 to 4-hour at 37uC with shaking. The bacteria were
collected by centrifuge, and the bacterial pellet was resuspended in
26 loading buffer. The bacterial culture supernatants were
sterilized by passing through a 0.2 mm filter, and proteins were
precipitated with trichloroacidic acid (TCA) and subjected to 10–
20% gradient SDS/PAGE. The Hcp polyclonal antibodies were
generated by New England Peptide (Gardner, MA).
Plaque formation assay
Two millilitre bacteria grown in LB broth for 16-hour were
pelleted by centrifugation at 7600 rpm for 5 min, washed once,
and resuspended in the same volume of SorC buffer. One hundred
microliters of the bacteria were plated on SM/5 agar plate.
Dictyostelium amoebae cells from mid-logarithmic cultures were
collected by centrifugation, washed once with SorC buffer, and
different number of amoebae cells (5610
4;1 610
4;5 610
3;3 610
3;
1610
3;5 610
2;1 610
2;5 610
1;1 610
1;5 610
0, respectively) in 5 ml
SorC buffer were deposited on the top of the agar plates with V.
cholerae wild type and different mutants. The plates were allowed to
dry under a sterile flow of air and then were incubated at 22uC for
3–5 days. The plaques formed by Dictyostelium amoebae were
recorded (see Fig. 3A for examples of plaque visualization). The
least number of Dictyostelium amoebae cells deposited above that
was able to form plaque on the bacterial lawns was defined as the
minimum number of Dictostelium cells required for plaque
formation in this study.
Bacterial killing assay
The bacterial killing experiment was performed as described
[9]. Briefly, V. cholerae and E. coli K12 CC114 were mixed at a
multiplicity of infection (MOI) of 10. Twenty microliters of the
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for 3.5 hours. Bacterial spots were harvested and resuspended in
1 ml of LB broth. The colony-forming unit (cfu) per milliliter of
surviving V. cholerae and E. coli were measured by a serial dilution
and selective growth on LB agar plates containing 100 mg/ml
streptomycin (for V. cholerae) and 12 mg/ml tetracycline (for E.coli)
respectively.
Actin cross-linking assay
Actin cross-linking assay was performed as described previously
[5]. Briefly, J774 cells were seeded into six-well tissue culture plates
at a density of 10
6 cells per well. After 16-hour incubation at 37uC,
cells were infected with various V. cholerae strains. The infections
were performed at a MOI of 10 for 3-hour. Cells were harvested
and resuspended in 50 mlo f2 6 loading buffer, and 10 ml each
Table 2. Strains and plasmids for this study.
Strain or plasmid Description Reference or source
V. cholerae
V52 Wild type, Strep
R [5]
Dvca0105 V52, in frame deletion of amino acid 1 to 61 from VCA0105 This study
Dvca0106 V52, in frame deletion of amino acid 34 to 356 from VCA0106 This study
DvipA V52, in frame deletion of amino acid 8 to 163 from VCA0107 This study
DvipB V52, in frame deletion of amino acid 12 to 486 from VCA0108 This study
Dvca0109 V52, in frame deletion of amino acid 4 to 142 from VCA0109 This study
DvasA V52, in frame deletion of amino acid 5 to 554 from VCA0110 This study
Dvca0111 V52, in frame deletion of amino acid 14 to 313 from VCA0111 This study
Dvca0112 V52, in frame deletion of amino acid 1 to 488 from VCA0112 This study
Dvca0113 V52, in frame deletion of amino acid 1 to 152 from VCA0113 This study
Dvca0114 V52, in frame deletion of amino acid 2 to 413 from VCA0114 This study
DvasF V52, in frame deletion of VCA0115 [5]
DclpV V52, in frame deletion of amino acid 3 to 850 from VCA0116 This study
DvasH V52, in frame deletion of VCA0117 This study
Dvca0118 V52, in frame deletion of amino acid 12 to 225 from VCA0118 This study
Dvca0119 V52, in frame deletion of amino acid 3 to 468 from VCA0119 This study
DvasK V52, in frame deletion of VCA0120 [5]
Dvca0121 V52, in frame deletion of amino acid 1 to 421 from VCA0121 This study
Dvca0122 V52, in frame deletion of amino acid 10 to 48 from VCA0122 This study
DvgrG-3 V52, in frame deletion of VCA0123 [20]
DvgrG-2 V52, in frame deletion of VCA0018 [20]
Dvca0020 V52, in frame deletion of amino acid 3 to 1077 from VCA0020 This study
Dvca19–21 V52, in frame deletion of genes from VCA0019 to VCA0021 This study
DvgrG-1 V52, in frame deletion of VC1416 [20]
Dvc1418 V52, in frame deletion of amino acid 2 to 626 from VC1418 This study
Dvc17–21 V52, in frame deletion of genes from VC1417 to VC1421 This study
Dhcp-1/2 V52, in frame deletion of VCA0017 and VC1415 [5]
DvgrG-1/3 V52, in frame deletion of VCA0123 and VC1416 This study
DepsD V52, in frame deletion of amino acid 49 to 670 from VC2733 This study
DrtxA V52, in frame deletion of rtxA This study
DrtxA vca0118 V52, in frame deletion of rtxA and VCA0118 This study
DrtxA vgrG-1 V52, in frame deletion of rtxA and vgrG-1 This study
DrtxA vasK V52, in frame deletion of rtxA and vasK This study
E. coli
DH5a pir fhuA2 D(argF-lacZ)U169 phoA glnV44 W80 D(lacZ)M15 gyrA96 recA1 relA1
endA1 thi-1 hsdR17 pir
[43]
SM10 pir thi thr leu tonA lacY supE recA-RP4-2-Tc-Mu pir [44]
Plasmid
pDS132 pCVD442 modified suicide plasmid, pir dependent, sacB, Cm
R,[ 4 0 ]
pTL61T Amp
R, lacZ reporter vector [41]
pBBR1MCS2 Km
R, broad host range [45]
doi:10.1371/journal.pone.0023876.t002
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the dilution at 1:1,000.
b-galactosidase assays
Bacteria were grown in LB broth overnight at 37uC. Beta-
galactosidase activities were determined with cells permeabilized
with SDS and chloroform as described by Miller [42].
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